top of page

VIP BLOG


Roche's Alzheimer's Blood Test Could Be the Next Big Healthcare Catalyst
At our October monthly meeting, VIP decided to invest in Roche, the Swiss multinational healthcare company who is leading the development and testing of new Alzheimer's drugs and diagnostic tools - Our thesis is below: Alzheimer’s disease remains one of the most devastating — and costly — health challenges worldwide. Traditional diagnosis methods rely on brain scans or spinal taps that are expensive, invasive, and often come too late. But Swiss healthcare leader Roche ( OTC:
Marcus Kuhnert
Nov 63 min read
Â
Â
Â


Wired for the Age of AI: The Copper Bet Behind the Machines
At Friday's monthly meeting, VIP decided to invest in a pure-play Canadian-based copper mining company - Our thesis is below: The rise of...
Marcus Kuhnert
Sep 292 min read
Â
Â
Â


Importance of Position Sizing in Investment Strategies
"Maximize Gains, Minimize Risks: The Power of Prudent Position Sizing" Position sizing is a critical element of portfolio management that...
Marcus Kuhnert
Sep 192 min read
Â
Â
Â


Understanding Stop Loss Orders: A Vital Tool for Managing Investment Risk
Managing risk is as crucial as securing profits. In the dynamic world of investing, managing risk is as crucial as securing profits. A...
Marcus Kuhnert
Sep 162 min read
Â
Â
Â


Breaking Down the Basics: How to Read a Stock Chart for Beginners
A practical, educational piece aimed at novice investors showing them how to understand trends, volume, and key indicators. For...
Marcus Kuhnert
Sep 102 min read
Â
Â
Â


Top 5 Mistakes New Investors Make (and How to Avoid Them)
Common pitfalls that investors makes and actionable tips to build good investing habits. Investing is crucial for building wealth over...
Marcus Kuhnert
Sep 102 min read
Â
Â
Â


"Why join an Investment Club?" The Power of Collective Learning and Investing
How pooling knowledge, resources, and ideas can boost confidence and returns for every investor in the group. Investing in the stock...
Marcus Kuhnert
Aug 292 min read
Â
Â
Â
Please note that nothing we write should ever be considered individual investment advice, as we are not licensed to provide such guidance.
This material is for educational purposes only, and we recommend consulting with a licensed financial advisor for individual investment advice.
bottom of page
